HectorRicardoVillarragaMD
Cardiology • Rochester, MNEchocardiography, Non-Invasive Cardiology, Preventive Cardiology
Associate Professor, Cardiovascular diseases and Internal Medicine, Mayo Medical School
Dr. Villarraga is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st Street SW
Rochester, MN 55905
Education & Training
Physicians Medical Center CarrawayResidency, Internal Medicine, 2002 - 2004
Mayo ClinicEchocardiography, 1995 - 1997
Fundacion Valle Del Lili/Universidad del Valle FellowshipFellowship, 1993 - 1995- Universidad del ValleInternal Medicine Residency, 1989 - 1992
Universidad del Valle Health SciencesClass of 1987
Certifications & Licensure
AZ State Medical License 2018 - 2026
FL State Medical License 2017 - 2026
IA State Medical License 2007 - 2025
MN State Medical License 2006 - 2025
WI State Medical License 2020 - 2025
AL State Medical License 2003 - 2006- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
- The National Board of EchocardiographyDiplomate in Adult Comprehensive Echocardiography
Awards, Honors, & Recognition
- FESC European Society of Cardiology
- FASE American Society of Echocardiography
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- 252 citationsRight ventricular strain for prediction of survival in patients with pulmonary arterial hypertension.Arun Sachdev, Hector R. Villarraga, Robert P. Frantz, Michael D. McGoon, Ju Feng Hsiao
Chest. 2011-06-01 - 251 citationsEvaluation and Management of Patients With Heart Disease and Cancer: Cardio-OncologyJoerg Herrmann, Amir Lerman, Nicole P. Sandhu, Hector R. Villarraga, Sharon L. Mulvagh
Mayo Clinic Proceedings. 2014-09-01 - 39 citationsThe utility of cardiac biomarkers and echocardiography for the early detection of bevacizumab- and sunitinib-mediated cardiotoxicity.Kimberly Ann Bordun, Sheena Premecz, Megan daSilva, Soma Mandal, Vineet Goyal
American Journal of Physiology. Heart and Circulatory Physiology. 2015-08-15
Abstracts/Posters
- Treatment and Lifestyle Risk Factors for Cardiovascular Disease Post Lymphoma Diagnosis: A Prospective Study in the Modern Treatment EraHector R Villarraga, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Lectures
- Mayo Cardiovascular Review Course for Cardiology Boards and Recertification with Echo Focus SessionMayo School of Continuous Professional Development, Rochester, Minnesota - 9/20/2013
- Echocardiography in the Nation's Capital: Focus for the Physician and SonographerMayo School of Continuous Professional Development, Washington, Dist Of Col - 4/13/2013
Press Mentions
#MayoClinicRadio Podcast: 6/29/19July 1st, 2019- Mayo Clinic Minute: When Cancer Treatment Hurts Your HeartMay 14th, 2019
Heart Failure Risk Increases for Breast Cancer, Lymphoma SurvivorsFebruary 28th, 2018- Join now to see all
Professional Memberships
- Member
- Fellow
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
